---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-002954"
form_type: "8-K"
ticker: "NRC"
cik: "0000070487"
company_name: "NRC HEALTH"
filed_at: "2022-02-10T23:59:59+00:00"
generated_at: "2026-06-27T09:22:24.842234+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# National Research Q4 revenue +10% to $38.3M, EPS $0.38; FY revenue +11% to $148.0M

## Summary
- Q4 2021 revenue $38.3M (+10% YoY); operating income $12.9M (+26%); diluted EPS $0.38 vs $0.32.
- Full-year 2021 revenue $148.0M (+11%); operating income $50.3M (+18%); diluted EPS $1.46 vs $1.45.
- Cash flow from operations $46.3M (up 14%); net cash position $27.8M, up from $4.1M at year-end 2020.
- Launched Health's Human Understanding Program to personalize patient care at scale.
- Continued quarterly dividend and share repurchases funded by strong cash flow.

## SEC filing metadata
- accession: 0001437749-22-002954
- form_type: 8-K
- ticker: NRC
- cik: 0000070487
- company_name: NRC HEALTH
- filed_at: 2022-02-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70487/000143774922002954/0001437749-22-002954-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70487/000143774922002954/nrc20220209_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-002954
- JSON: https://secwatch.observer/filing/0001437749-22-002954.json
- Plain text: https://secwatch.observer/filing/0001437749-22-002954.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.